 - radiation therapy 3. Patient has not recovered from reversible toxicity due to any prior therapies e.g. returned to baseline or Grade 1 except for hematological laboratory parameters Note: Patient does not meet this criteria if the toxicity is stable and irreversible, and there is no evidence that panobinostat causes a similar toxicity 4. Patient has received prior treatment with DAC inhibitors including panobinostat 